121 related articles for article (PubMed ID: 8655674)
1. Inverse relation of serum Helicobacter pylori antibody titres and extent of intestinal metaplasia.
Osawa H; Inoue F; Yoshida Y
J Clin Pathol; 1996 Feb; 49(2):112-5. PubMed ID: 8655674
[TBL] [Abstract][Full Text] [Related]
2. Serum anti-Helicobacter pylori IgG antibodies and pepsinogens A and C as serological markers of chronic atrophic gastritis.
Sitas F; Smallwood R; Jewell D; Millard PR; Newell DG; Meuwissen SG; Moses S; Zwiers A; Forman D
Cancer Epidemiol Biomarkers Prev; 1993; 2(2):119-23. PubMed ID: 8467246
[TBL] [Abstract][Full Text] [Related]
3. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
4. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
[TBL] [Abstract][Full Text] [Related]
5. Mucosal IgA antibody against Helicobacter pylori in chronic gastritis and intestinal metaplasia detected by the Tes-Tape method in resection specimens after gastrectomy for gastric cancer.
Matsukura N; Onda M; Tokunaga A; Matsuda N; Yamashita K
Cancer; 1995 Mar; 75(6 Suppl):1472-7. PubMed ID: 7889477
[TBL] [Abstract][Full Text] [Related]
6. Atrophic changes of gastric mucosa are caused by Helicobacter pylori infection rather than aging: studies in asymptomatic Japanese adults.
Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Koshiyama H; Takeda H; Yoshida J; Graham DY
Helicobacter; 1996 Mar; 1(1):52-6. PubMed ID: 9398913
[TBL] [Abstract][Full Text] [Related]
7. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
Cao Q; Ran ZH; Xiao SD
J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
[TBL] [Abstract][Full Text] [Related]
8. Spontaneous disappearance of Helicobacter pylori antibodies in patients with advanced atrophic corpus gastritis.
Kokkola A; Kosunen TU; Puolakkainen P; Sipponen P; Harkonen M; Laxen F; Virtamo J; Haapiainen R; Rautelin H
APMIS; 2003 Jun; 111(6):619-24. PubMed ID: 12969017
[TBL] [Abstract][Full Text] [Related]
9. Serum anti-Helicobacter pylori immunoglobulin G titer correlates with grade of histological gastritis, mucosal bacterial density, and levels of serum biomarkers.
Tu H; Sun L; Dong X; Gong Y; Xu Q; Jing J; Yuan Y
Scand J Gastroenterol; 2014 Mar; 49(3):259-66. PubMed ID: 24329006
[TBL] [Abstract][Full Text] [Related]
10. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
[TBL] [Abstract][Full Text] [Related]
11. Atrophic gastritis and intestinal metaplasia in Helicobacter pylori infection: the role of CagA status.
Sozzi M; Valentini M; Figura N; De Paoli P; Tedeschi RM; Gloghini A; Serraino D; Poletti M; Carbone A
Am J Gastroenterol; 1998 Mar; 93(3):375-9. PubMed ID: 9517643
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori serology in chronic gastritis with antral atrophy and negative histology for Helicobacter-like organisms.
Testoni PA; Colombo E; Cattani L; Longhi M; Bagnolo F; Lella F; Buizza M; Scelsi R
J Clin Gastroenterol; 1996 Apr; 22(3):182-5. PubMed ID: 8724254
[TBL] [Abstract][Full Text] [Related]
13. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
Schlemper RJ; van der Werf SD; Vandenbroucke JP; Biemond I; Lamers CB
Gut; 1995 Aug; 37(2):199-204. PubMed ID: 7557568
[TBL] [Abstract][Full Text] [Related]
14. Fasting gastric pH of Japanese subjects stratified by IgG concentration against Helicobacter pylori and pepsinogen status.
Kishikawa H; Nishida J; Ichikawa H; Kaida S; Takarabe S; Matsukubo T; Miura S; Morishita T; Hibi T
Helicobacter; 2011 Dec; 16(6):427-33. PubMed ID: 22059393
[TBL] [Abstract][Full Text] [Related]
15. Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects.
Kreuning J; Lindeman J; Biemond I; Lamers CB
J Clin Pathol; 1994 Mar; 47(3):227-31. PubMed ID: 8163693
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
[TBL] [Abstract][Full Text] [Related]
17. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
[TBL] [Abstract][Full Text] [Related]
18. The effect of the immune response to Helicobacter pylori in the development of intestinal metaplasia.
Sugiyama T; Awakawa T; Hayashi S; Hisano K; Yabana T; Kurokawa I; Yachi A
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S89-92. PubMed ID: 7735943
[TBL] [Abstract][Full Text] [Related]
19. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
[TBL] [Abstract][Full Text] [Related]
20. Serum anti-
Toyoshima O; Nishizawa T; Sakitani K; Yamakawa T; Takahashi Y; Yamamichi N; Hata K; Seto Y; Koike K; Watanabe H; Suzuki H
World J Gastroenterol; 2018 Sep; 24(35):4061-4068. PubMed ID: 30254410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
